Decoding 14 Analyst Evaluations For Illumina
Portfolio Pulse from Benzinga Insights
In the past three months, 14 analysts have provided ratings for Illumina (NASDAQ:ILMN), with a mix of bullish and indifferent sentiments. The average 12-month price target is $166.5, slightly down from the previous $166.67. Illumina faces financial challenges, including a revenue decline and high debt-to-equity ratio.
October 10, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Illumina has received mixed analyst ratings, with a slight decrease in the average price target to $166.5. The company faces financial challenges, including a revenue decline and high debt-to-equity ratio, which may impact its stock performance.
The mixed analyst ratings and slight decrease in price target suggest a neutral short-term impact on Illumina's stock. However, the company's financial challenges, such as declining revenue and high debt, could pose risks to its stock performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100